RyboDyn

United States · Biotech · AI · Enterprise software

Decodes the dark proteome using an AI-powered novel sequencing and discovery platform to reveal novel cancer targets

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$10MGenedant — Role not disclosedMassive Tech Ventures — Role not disclosedP2V — Role not disclosedSeaX Ventures — Role not disclosedSOSV — Role not disclosedSwell VC — Role not disclosed
Sourcesrybodyn.com ↗